高流量鼻カニューレ市場：コンポーネント、適応症、エンドユーザー別-2025-2030年の世界予測

高流量鼻カニューレ市場は、2023年に31億1,000万米ドルと評価され、2024年には33億8,000万米ドルに達すると予測され、CAGR 9.17％で成長し、2030年には57億6,000万米ドルになると予測されています。

高流量鼻カニューレ（HFNC）は、標準的な鼻カニューレよりも高い流量で酸素療法を行うために設計された医療機器です。このシステムは主に、酸素供給の強化と加湿の改善が重要な呼吸器疾患患者の治療に使用されます。その範囲には、クリティカルケア環境における酸素供給量のモニタリングや、患者の快適性の向上が含まれ、特に呼吸困難で酸素補給を必要とする新生児、小児、成人患者を対象としています。HFNCシステムの必要性は、COPD、肺炎、COVID-19による最近の急増といった呼吸器疾患の有病率の増加により高まっています。用途は病院、クリニック、家庭環境と幅広く、エンドユーザーにはヘルスケア施設や長期の酸素療法を必要とする患者が含まれます。

HFNC市場は、医療技術の進歩、患者中心のケアの重視の高まり、高齢化、世界の入院者数の増加によって、効率的な呼吸補助装置の需要に拍車がかかっています。最近のビジネスチャンスは、新興国市場での認知度向上と採用、研究開発活動の強化、患者パラメータをより正確に監視するための人工知能の統合から生じています。しかし、機器コストの高さ、適切な償還政策の欠如、代替治療ソリューションの存在といった要因が課題となっています。新興国市場における予算の制約や、革新的製品の市場投入までの時間に影響を与える規制上のハードルも、市場の成長を妨げる可能性があります。

技術革新の範囲には、携帯性向上のための機器の小型化、遠隔医療機能の拡大、個別化ケアのためのリアルタイムデータ分析を提供するスマートモニタリングシステムの開発などが含まれます。機器製造に環境に優しい素材を取り入れ、シームレスな在宅ケアのためのウェアラブル技術を模索することも成長の可能性をもたらします。市場参入企業は、市場のダイナミックな性質を理解した上で、費用対効果が高く、かつ先進的なHFNCシステムの開発に投資し、戦略的提携を結んで未開拓の地域に進出し、ヘルスケア技術展示会に積極的に参加してイノベーションをアピールすべきです。進化するヘルスケア政策と患者のニーズに合わせることで、企業はHFNC市場における今後の機会を効果的に活用することができます。

市場力学：急速に進化する高流量鼻カニューレ市場の主要市場インサイトを公開

高流量鼻カニューレ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 急性呼吸不全と睡眠時無呼吸症候群の有病率の増加
  • 小児の気管支炎と肺炎の治療におけるHFNCの利用の増加
  • 在宅ケアにおける非侵襲的人工呼吸と持続的陽圧呼吸のニーズの高まり
• 市場抑制要因
  • 従来のカニューレに比べ比較的高コスト
• 市場機会
  • 高流量鼻カニューレにおける技術の進歩
  • 商業化を支える有利な規制枠組み
• 市場の課題
  • 高流量鼻カニューレのモニターなし使用に伴うモダリティと合併症

ポーターの5つの力：高流量鼻カニューレ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、高流量鼻カニューレ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：高流量鼻カニューレ市場における外部からの影響の把握

外部マクロ環境要因は、高流量鼻カニューレ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析高流量鼻カニューレ市場における競合情勢の把握

高流量鼻カニューレ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス高流量鼻カニューレ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、高流量鼻カニューレ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 急性呼吸不全と睡眠時無呼吸症の罹患率の増加
    • 小児の気管支炎および肺炎の治療におけるHFNCの利用増加
    • 在宅ケア環境における非侵襲的換気と持続陽圧呼吸の必要性の高まり
  • 抑制要因
    • 従来のカニューレに比べて比較的高価
  • 機会
    • 高流量鼻カニューレにおける技術的進歩
    • 商業化を支援する有利な規制枠組み
  • 課題
    • 高流量鼻カニューレの監視なしの使用に関連するモダリティと合併症
• 市場セグメンテーション分析
  • コンポーネント：酸素レベルを正確に調整する重要な機能を提供する空気酸素ブレンダーの大幅な採用
  • エンドユーザー：幅広い患者と臨床シナリオをサポートするために、病院で高流量鼻カニューレの使用が増えています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 高流量鼻カニューレ市場：コンポーネント別

• アクティブ加湿器
• 空気酸素ブレンダー
• 加熱吸気回路
• 鼻カニューレ

第7章 高流量鼻カニューレ市場適応症別

• 急性心不全
• 急性呼吸不全
• 気管支拡張症
• 一酸化炭素毒性
• 慢性閉塞性肺疾患

第8章 高流量鼻カニューレ市場：エンドユーザー別

• 外来診療センター
• 病院
• 長期ケアセンター

第9章 南北アメリカの高流量鼻カニューレ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の高流量鼻カニューレ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの高流量鼻カニューレ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 赤ちゃんの呼吸サポートを最善にするために、細気管支炎の新しい試験が開始されました
  • テレセア、ボンハワフロー酸素療法システムでFDAの承認を獲得
  • マーシーフライトが高リスク呼吸器疾患患者向けに高流量鼻カニューレを実施

企業一覧

• SunMed, LLC
• Flexicare（Group）Limited
• ResMed, Inc.
• Armstrong Medical Limited
• ICU Medical, Inc.
• Fairmont Medical Products Pty Ltd.
• Vapotherm, Inc.
• Masimo Corporation
• Dragerwerk AG & Co. KGaA
• BMC Medical Co., Ltd.
• Heka Medicals India Private Limited
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Corporation Limited
• Well Lead Medical Co., Ltd.
• Vyaire Medical, Inc.
• Narang Medical Limited
• Teleflex Incorporated
• MEKICS Co., Ltd.
• Great Group Medical Co., Ltd.
• Allied Medical Limited
• Guangdong Pigeon Medical Apparatus Co.,Ltd.
• Hamilton Medical AG
• Synergy Intact Private Limited
• nice Neotech Medical Systems Pvt. Ltd.
• Sterimed Group

LIST OF FIGURES

• FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
• FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
• TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 53. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 120. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

The High-flow Nasal Cannula Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 9.17%, to USD 5.76 billion by 2030.

The high-flow nasal cannula (HFNC) is a medical device designed for delivering oxygen therapy at a higher flow rate than standard nasal cannulas. This system is primarily used in the treatment of patients with respiratory diseases where enhanced oxygen delivery and improved humidification are critical. The scope includes monitoring oxygen delivery in critical care settings and improving patient comfort, particularly in neonatal, pediatric, and adult patients suffering from respiratory distress and requiring supplemental oxygen. The necessity for HFNC systems has grown due to an increased prevalence of respiratory conditions such as COPD, pneumonia, and recent surge due to COVID-19. Applications are broadly in hospitals, clinics, and home settings, with end-users including healthcare facilities and patients requiring long-term oxygen therapy.

The HFNC market is being driven by advancements in medical technology, a heightened emphasis on patient-centric care, the aging population, and increased hospital admissions globally, which spur the demand for efficient breathing assistance devices. Recent opportunities arise from growing awareness and adoption in emerging markets, enhanced research and development activities, and the integration of artificial intelligence to monitor patient parameters more accurately. However, factors like high equipment costs, lack of adequate reimbursement policies, and the presence of alternative therapeutic solutions pose challenges. Market growth could be hampered by budget constraints in developing regions and regulatory hurdles impacting the time-to-market for innovative products.

Innovation scopes include the miniaturization of devices for improved portability, expanding telehealth capabilities, and the development of smart monitoring systems that deliver real-time data analytics for personalized care. Incorporating eco-friendly materials in device manufacturing and exploring wearable technologies for seamless home care also offer growth potential. Understanding the dynamic nature of the market, businesses should invest in creating cost-effective yet advanced HFNC systems, form strategic alliances to penetrate untapped regions, and actively participate in healthcare tech exhibitions to showcase innovation. By aligning with evolving healthcare policies and patient needs, companies can effectively harness upcoming opportunities in the HFNC market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
  • Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
  • Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
• Market Restraints
  • Relatively High Cost Compared to Traditional Cannula
• Market Opportunities
  • Technological Advancements in High-Flow Nasal Cannula
  • Favorable Regulatory Framework Supporting Commercialization
• Market Challenges
  • Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula

Porter's Five Forces: A Strategic Tool for Navigating the High-flow Nasal Cannula Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High-flow Nasal Cannula Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High-flow Nasal Cannula Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High-flow Nasal Cannula Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High-flow Nasal Cannula Market

A detailed market share analysis in the High-flow Nasal Cannula Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High-flow Nasal Cannula Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High-flow Nasal Cannula Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include SunMed, LLC, Flexicare (Group) Limited, ResMed, Inc., Armstrong Medical Limited, ICU Medical, Inc., Fairmont Medical Products Pty Ltd., Vapotherm, Inc., Masimo Corporation, Dragerwerk AG & Co. KGaA, BMC Medical Co., Ltd., Heka Medicals India Private Limited, Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Well Lead Medical Co., Ltd., Vyaire Medical, Inc., Narang Medical Limited, Teleflex Incorporated, MEKICS Co., Ltd., Great Group Medical Co., Ltd., Allied Medical Limited, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Synergy Intact Private Limited, nice Neotech Medical Systems Pvt. Ltd., and Sterimed Group.

Market Segmentation & Coverage

This research report categorizes the High-flow Nasal Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit, and Nasal Cannula.
• Based on Indication, market is studied across Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis, Carbon Monoxide Toxicity, and Chronic Obstructive Pulmonary Disease.
• Based on End User, market is studied across Ambulatory Care Centers, Hospitals, and Long-Term Care Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
    • 5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
    • 5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively High Cost Compared to Traditional Cannula
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
    • 5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
  • 5.1.4. Challenges
    • 5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
  • 5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. High-flow Nasal Cannula Market, by Component

• 6.1. Introduction
• 6.2. Active Humidifier
• 6.3. Air Oxygen Blender
• 6.4. Heated Inspiratory Circuit
• 6.5. Nasal Cannula

7. High-flow Nasal Cannula Market, by Indication

• 7.1. Introduction
• 7.2. Acute Heart Failure
• 7.3. Acute Respiratory Failure
• 7.4. Bronchiectasis
• 7.5. Carbon Monoxide Toxicity
• 7.6. Chronic Obstructive Pulmonary Disease

8. High-flow Nasal Cannula Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Care Centers
• 8.3. Hospitals
• 8.4. Long-Term Care Centers

9. Americas High-flow Nasal Cannula Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific High-flow Nasal Cannula Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa High-flow Nasal Cannula Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
  • 12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
  • 12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness

Companies Mentioned

• 1. SunMed, LLC
• 2. Flexicare (Group) Limited
• 3. ResMed, Inc.
• 4. Armstrong Medical Limited
• 5. ICU Medical, Inc.
• 6. Fairmont Medical Products Pty Ltd.
• 7. Vapotherm, Inc.
• 8. Masimo Corporation
• 9. Dragerwerk AG & Co. KGaA
• 10. BMC Medical Co., Ltd.
• 11. Heka Medicals India Private Limited
• 12. Koninklijke Philips N.V.
• 13. Fisher & Paykel Healthcare Corporation Limited
• 14. Well Lead Medical Co., Ltd.
• 15. Vyaire Medical, Inc.
• 16. Narang Medical Limited
• 17. Teleflex Incorporated
• 18. MEKICS Co., Ltd.
• 19. Great Group Medical Co., Ltd.
• 20. Allied Medical Limited
• 21. Guangdong Pigeon Medical Apparatus Co.,Ltd.
• 22. Hamilton Medical AG
• 23. Synergy Intact Private Limited
• 24. nice Neotech Medical Systems Pvt. Ltd.
• 25. Sterimed Group